
Theratechnologies THTX
Geschäftsbericht 2024
hinzugefügt 21.03.2026
Theratechnologies DPO 2011-2026 | THTX
DPO Jährlich Theratechnologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 279 | 171 | 285 | 75.5 | 50.4 | - | 31 K |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 31 K | 50.4 | 5.31 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Lipocine
LPCN
|
59.8 | $ 7.4 | 1.23 % | $ 39 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
31.7 | $ 19.47 | 1.25 % | $ 910 M | ||
|
Lexicon Pharmaceuticals
LXRX
|
11.9 K | $ 1.68 | 2.13 % | $ 610 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
72.6 | $ 0.74 | 21.89 % | $ 8.48 M | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Exelixis
EXEL
|
148 | $ 41.51 | 0.23 % | $ 11.3 B | ||
|
MediWound Ltd.
MDWD
|
76.8 | $ 16.64 | -1.42 % | $ 453 M | ||
|
Mesoblast Limited
MESO
|
1.25 K | $ 14.31 | 2.07 % | $ 9.29 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.61 | -0.76 % | $ 16.4 M | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
23 | $ 4.34 | -1.92 % | $ 832 M | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | ||
|
Ionis Pharmaceuticals
IONS
|
815 | $ 69.55 | -1.75 % | $ 11.1 B | ||
|
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | ||
|
Longeveron
LGVN
|
241 | $ 0.87 | -8.8 % | $ 15.3 B |